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Forces and Disease: Electrostatic 
force differences caused by 
mutations in kinesin motor 
domains can distinguish between 
disease-causing and non-disease-
causing mutations
Lin Li1, Zhe Jia1, Yunhui Peng1, Subash Godar1, Ivan Getov2, Shaolei Teng3, Joshua Alper  1 & 
Emil Alexov  1
The ability to predict if a given mutation is disease-causing or not has enormous potential to 
impact human health. Typically, these predictions are made by assessing the effects of mutation on 
macromolecular stability and amino acid conservation. Here we report a novel feature: the electrostatic 
component of the force acting between a kinesin motor domain and tubulin. We demonstrate that 
changes in the electrostatic component of the binding force are able to discriminate between disease-
causing and non-disease-causing mutations found in human kinesin motor domains using the receiver 
operating characteristic (ROC). Because diseases may originate from multiple effects not related to 
kinesin-microtubule binding, the prediction rate of 0.843 area under the ROC plot due to the change 
in magnitude of the electrostatic force alone is remarkable. These results reflect the dependence of 
kinesin’s function on motility along the microtubule, which suggests a precise balance of microtubule 
binding forces is required.
The ability to predict if genetic mutations cause disease or not has enormous potential to impact human health1, 2. 
Efforts to make these predictions to date have largely been done by assessing the effect of a genetic mutation on 
the coded protein’s stability and amino acid conservation3, 4. While these predictions have had some success based 
on genome-wide work5, when considering the disease-causing effects of mutations in particular protein families, 
other, more function specific, features may be more successful6, 7.
The kinesin superfamily of microtubule motor proteins is responsible for a diverse set of cell biological func-
tions including intracellular transport, ciliary assembly, mitosis, meiosis, cytoskeletal morphology, and micro-
tubule dynamics regulation8, 9. These functions depend on kinesin’s force generating and motile properties10, 11. 
Kinesins, for example, are particularly critical to the development of neurons due to their ability to transport 
intracellular cargos, including synaptic vesicles, mitochondria, and newly synthesized protein complexes from 
the endoplasmic reticulum near the nucleus in the cell body to the growing tips of axons and dendrites12. Kinesins 
enable elongated neurons, sometimes more than a meter long, to overcome physical limitations associated with 
long distance diffusion13.
To accomplish the diversity of functions that kinesins perform, there are 14 recognized and numbered families 
of kinesins8, 14, as well as numerous ungrouped, or orphan, kinesins8. Most members of the kinesin superfamily 
are microtubule plus end-directed motors12. Some notable exceptions include kinesin-13s, which are primarily 
involved in regulation of microtubule dynamics15 and move by diffusion16, and kinesin-14s, which are minus 
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end-directed motors17, 18. Kinesin motor motility and pN-scale forces arise from structural changes in the neck 
linker subdomains19, 20 of kinesins upon hydrolysis of ATP21. However, these forces are not the only forces within 
kinesins that are critical to their function.
The forces of binding between a kinesin and the microtubule are additionally important to the motor’s pro-
cessivity, which is a motility property determined by how far it moves along a microtubule before completely 
dissociating13. A single bound kinesin motor domain is in a state of force equilibrium in the absence of external 
loading, meaning that the sum of all forces between the microtubule and the kinesin must be zero. These forces 
are electrostatic and non-electrostatic forces, including hydrogen bonds and salt bridges, van der Waals forces, 
as well as others. However, because the charge of amino acids at the microtubule binding interface greatly affects 
the motility and microtubule-stimulated ATPase rate of kinesin22, the dominant force associated with binding is 
likely the electrostatic force. Electrostatic forces guide kinesin-1 to its binding site23 and allow it to follow a single 
protofilament24, 25. Electrostatic forces also likely underlie the diffusive motility of kinesin-826, 27 and kinesin-1316.
Kinesins are critical to cell biology, so they are also important to many aspects of life, particularly to cell 
division and the nervous system. Genetic defects in kinesin motor domains that cause errors in cell division are 
likely embryonic lethal. Somatic defects are found in and are distributed throughout many kinesins, including 
the motor domains28. These defects are prevalent in endometrial cancer, lung squamous cell carcinoma, and 
melanoma28. However, somatic defects are generally unique to single samples making it difficult to discern 
their significance to the cancer28. Multiple congenital disorders are caused by non-synonymous single nucle-
otide polymorphisms (nsSNPs) in kinesin motor domains, including nsSNPs in the kinesin-1 family member 
KIF5A that cause parkinsonism29, peripheral neuropathy29–32, Charcot–Marie–Tooth disease type 233, retini-
tis pigmentosa29, and spastic paraplegia33–35; nsSNPs in the kinesin-1 family member KIF5C and the kinesin-5 
family member KIF11 that cause microcephaly36, 37; nsSNPs in the kinesin-10 family member KIF22 that cause 
lepto-spondyloepimetaphyseal dysplasia38; nsSNPs in the kinesin-3 family member KIF1A that cause spastic 
paraparesis and sensory and autonomic neuropathy type-239; and nsSNPs in the kinesin-5 family member KIF11 
that cause primary lymphedema and chorioretinal dysplasia37.
Because nsSNPs in kinesins tend to cause neurological genetic disorders and electrostatic forces between 
the kinesin motor domain and the microtubule are critical to multiple physiological properties of kinesins that 
could be particularly important in neurons, we hypothesized that the nsSNPs found in kinesin motor domains 
that greatly affect the electrostatic forces acting between kinesin and microtubules would strongly correlate to 
the nsSNPs causing human disease. To probe this hypothesis, we investigated the effect of known kinesin motor 
domain nsSNPs on the electrostatic force between kinesin and tubulin dimers using computational techniques. 
This study is based on 50 nsSNPs causing missense mutations in the motor domains of 10 different genes coding 
for proteins from 8 different kinesin families identified from dbNSFP40 and annotated as disease-causing using 
the Human Gene Mutation Database41 and ClinVar42 complemented with 11 nsSNPs that do not cause disease 
taken from 1000 genomes project43. The goal is to determine whether the changes in the electrostatic forces 
caused by mutations can be used to discriminate disease-causing mutations from those that do not cause human 
disease.
Materials and Methods
Selection of kinesin nsSNPs. The kinesin nsSNPs were downloaded from dbNSFP40 and missense muta-
tions located in the coding regions of the kinesin motors domains with structures available in the PDB44 were 
selected. The Human Gene Mutation Database (HGMD)41 and ClinVar42 were used to identify disease-causing 
mutations. This resulted in the selection of 50 mutations in various kinesins.
A total of 11 nsSNPs with the allele frequency greater than 1% in the 1000 Genomes Project45 were identified 
and used as common, non-disease causing polymorphisms in the healthy individuals.
Note that significantly more disease-causing mutations were identified than non-disease-causing mutations, 
but the inclusion of mutations with allele frequency smaller than 1% may result in mutations with unknown phys-
iological importance. The list of all the mutations for this study is provided in Supplementary Materials Table S1.
Preparation of kinesin-tubulin structures. The 61 selected mutants come from 10 kinesin proteins rep-
resenting 8 kinesin families (Table 1). High resolution structures, those with better than 5 Å resolution and having 
no mutation, were downloaded from the Protein Data Bank (PDB)46 for 5 of the 10 kinesin proteins. If multiple 
structures were available for the same kinesin in PDB, the structure with the highest resolution was selected for 
this work.
High resolution structures were not available in the PDB for the other 5 kinesin proteins. Note that for some 
proteins, including KIF1A and KIF5A, structures were available, however, either the resolution was too low or the 
structure had mutations introduced into it. In the cases without structure, SWISS-MODEL47 was used to build 
protein homology models from templates with high sequence similarities. The top model from SWISS-MODEL 
was selected to model the corresponding kinesin motor structures.
Some of the structures had missing heavy atoms. Profix48 was used to fix these structures.
NAMD49 was used to perform a 10,000-step energy minimization for each structure. In NAMD minimiza-
tions, the CHARMM50 force field and the Generalized Born (GB) implicit solvent model were used.
There were no structures of the human kinesin-human tubulin complex available in PDB. However, there were 
many other kinesin-tubulin complex structures available, and kinesins share the same microtubule binding site22, 51. 
Therefore, kinesin-tubulin complex structures were made using Chimera52 to align each kinesin (Table 1) to the 
human α1A/β3 tubulin dimer structure (PDB ID 5JCO)53, using a model of human kinesin-5 and a mammalian 
tubulin dimer docked into a 9.5- Å cryo-EM map (PDB ID 4AQW)54 as a template. The C-termini (E-hooks) were 
not modeled since their structures are not available in the corresponding PDB files.
www.nature.com/scientificreports/
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Building complex structure via structural alignment of the backbone atoms resulted in atomic clashes 
at the binding interface. To remove these structural clashes introduced during the modeling process, the 
kinesin-tubulin complex structures underwent 2000 steps of energy minimization using the CHARMM3655 force 
field in CHARMM56 software in which only amino acid side chains were free to move because a 10 kcal·mol−1·Å−1 
harmonic constraint was placed on all backbone atoms.
The nsSNP structures were generated based on the wild type structure for each kinesin using PDB2PQR57. The 
protonation states of titratable group were assumed to be standard, roughly corresponding to pH = 7.0. Since the 
kinesins considered in this work are cytoplasmic kinesins, the physiological pH is 7.0. Only the mutated residue 
was energy optimized; all other atoms were kept in the same position as in the wild type structure to isolate the 
direct effects of electrostatic forces.
Force calculations. Electrostatic forces were calculated for each kinesin-tubulin complex using 
DelPhiForce58. The force reported is the net electrostatic force exerted on a kinesin by its tubulin dimer binding 
partner. The electrostatic force on each individual atom and residue, which is used to analyze the detailed force 
distribution on each kinesin, was also calculated with DelPhiForce.
The forces on each kinesin were calculated in two states: the bound state and the unbound state. The bound 
state was considered to be the equilibrium complex position, which was determined as described in “Preparation 
of kinesin-tubulin structures”. The unbound state was obtained by displacing the kinesin 5 Å from the tubulin in 
the direction along the line between the mass center of the kinesin and tubulin dimer. The dielectric constant for 
water and protein were set as 80 and 2, respectively; the resolution of the grid was set at 2 grids/Å; the perfil was 
set at 70; the ionic strength of the solvent was set at 0 (zero salt concentration was used to be consistent with our 
previous studies and to avoid the ambiguity associated with explicit ion binding). However, to check the sensitiv-
ity of results, parallel calculations were done at physiological salt concentration corresponding to ionic strength 
I = 0.15 M. The dipolar boundary condition was used in all cases. Information on these parameters is available in 
the DelPhi59, 60 manual (http://compbio.clemson.edu/downloadDir/delphi/delphi_manual.pdf).
The electrostatic force difference, ∆F , was defined as the difference between the electrostatic forces exerted on 
wild type and the corresponding mutant kinesins.
∆ = −F F F (1)mut wt
where ∆F  and are vector quantities with components ΔFlat (lateral direction), ΔFlong (longitude direction), and 
ΔFbind (binding direction).
The relative force difference ΔFrel is defined as:
∆ = −F F F F/ (2)rel mut wt wt
The relative force difference in the binding direction ΔFbind,rel is defined as
∆ = | − | | |¯ ¯ ¯F F F F/ (3)bind,rel bind,mut bind,wt bind,wt
where Fbind,mut and Fbind,wt are the components of the electrostatic force between the microtubule and the mutant 
and wild type kinesin in the binding direction, respectively.
Results
Electrostatic forces act between kinesin and tubulin. In our previous work, we demonstrated that 
the electrostatic forces on kinesin-5 form a binding funnel around the tubulin dimer58. A similar binding funnel 
was also found for dynein around the tubulin binding pocket61. In this work, we found that the binding funnel 
is common to kinesins, as shown for kinesin-13 as an example (Fig. 1), and that the electrostatic force guides the 












Kinesin-1 KIF5A Swiss model 3WRD.A – mouse kinesin 1 (KIF5C) apo 91.2 2.9 71
Kinesin-1 KIF5C Swiss model 5HNY.C – rat kinesin 1/Drosophila kinesin 14 chimera (KIF5C/NCD) AMPPNP 97.8 6.3 72
Kinesin-3 KIF1A Swiss model 2HXH.C – mouse kinesin 3 (KIF1A) ADP 95.9 11 73
Kinesin-4 KIF21A Swiss model 3ZFD.A – mouse kinesin 4 (KIF4) AMPPNP 57.1 1.7 74
Kinesin-4 KIF27 Swiss model 3ZFD.A - mouse kinesin 4 (KIF4) AMPPNP 52.5 1.7 74
Kinesin-5 KIF11 1II6.A ADP 2.1 75
Kinesin-8 KIF18A 3LRE.A ADP 2.2 68
Kinesin-9 KIF9 3NWN.A ADP 2.0 44
Kinesin-10 KIF22 3BFN.A ADP 2.3 44
Kinesin-13 KIF2C 2HEH.A ADP 2.2 44
Table 1. Details of the 10 wild type kinesin structures used.
www.nature.com/scientificreports/
4SCientifiC REPoRTs | 7: 8237  | DOI:10.1038/s41598-017-08419-7
Because the electrostatic force is a vector, F , we examined its components in the longitudinal (Flong), lateral 
(Flat), and binding (Fbind) directions (Fig. 2) separately to further assess the role of electrostatic forces. We found 
that the magnitude of the mean electrostatic force, | |Favg , for the 10 wild type kinesins used in this study in the 
bound state was 1,450 ± 170 pN (results for each kinesin are shown in Supplemental Material Table S1). 
Preforming the same calculations for unbound kinesins (at a displacement of 5 Å from the tubulin) resulted in an 
87% decrease in | |Favg  to 192 ± 56 pN. However, despite the large drop in magnitude, the direction of that mean 
force, and therefore the contribution of individual components, in the bound state was statistically indistinguish-
able from the unbound state (Table 2). The component of the mean electrostatic force in the binding direction, 
Fbind,avg, contributed the most to the force magnitude (Table 2), and the components in the lateral, Flat,avg, and 
longitudinal, Flong,avg, directions were not statistically different from zero (Table 2).
Electrostatic forces and diseases. We calculated the electrostatic force differences, ∆F  (Equation 1), of 
bound and unbound structures (Supplementary Material Table S1), where the force difference quantifies the dif-
ference in electrostatic force between the mutant and the corresponding wild type structure. Like the electrostatic 
force, force differences have three components in the longitudinal (ΔFlong), lateral (ΔFlat), and binding (ΔFbind) 
directions (Fig. 2). Besides the force differences, we also calculated the relative force difference ΔFrel (Equation 2). 
We found that mutations with larger values of relative force differences, ΔFrel, are more likely to cause disease 
(Supplementary Material Table S1).
We quantified the result that large ΔFrel tends to cause disease using Receiver Operating Characteristic 
(ROC) plots (Fig. 3). The area under an ROC plot indicates how well a descriptor, in this case ΔFrel, discriminates 
between two states, in this case whether a mutation is disease-causing or non-disease-causing. The area under an 
ROC plot of 1 indicates the descriptor can always discriminate between the states, and the area under a ROC plot 
of 0.5 (corresponding to the red dotted line in Fig. 3) indicates the descriptor is no better than random chance.
Figure 1. A funnel of electrostatic binding forces guides kinesin to the binding site on a tubulin dimer. The 
kinesin-13 structure (yellow) was shifted 20 Å away from its bound position and circled around the tubulin 
dimer (colored blue for positive surface charge and red for negative surface charge) along a circle with a radius 
of 40 Å. Every 30 degrees, the electrostatic force on the kinesin was calculated. These forces are represented by 
arrows (green) with their tail end located at the mass center of the kinesin in the 12 locations around the circle 
and their lengths proportional to the magnitude of the electrostatic force. (A) and (C) are the side views. (B) and 
(D) are the top views. In (A) and (B) the kinesin structure is shown at two positions for illustration of the range 
of displacement. In (C) and (D) the kinesin is hidden to provide clear view of the forces. In all frames, the total 
electrostatic forces were calculated using DelPhiForce and visualized with VMD76.
www.nature.com/scientificreports/
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We found that ΔFrel of unbound structures provided a better prediction of disease than ΔFrel of bound struc-
tures because the areas under the unbound state ROC plots were 0.84 and 0.84 for ΔFrel and ΔFbind,rel, respectively 
(Fig. 3) and the area under the bound state ROC plots were 0.79 and 0.77 for ΔFrel and ΔFbind,rel, respectively 
(Fig. 3). We also noted that ΔFrel performed slightly better than ΔFbind,rel for structures in bound states (Fig. 3). 
We obtained similar results from ROC plots (Supplementary Material Figure S1) of electrostatic force calculations 
at an ionic strength of 0.15 M, indicating that ionic strength does not play a role in discriminating disease-causing 
from non-disease-causing mutations. Thus, in the rest of the manuscript, we focus on results obtained with I = 0 
M. Since disease can be caused by either decreasing or increasing the wild type force, we did ROC using the abso-
lute values of ∆F  and |ΔFbind|, for both unbound and bound states, which resulted in similar as above perfor-
mance; areas under ROC curve ranged from 0.72 to 0.75 (Supplementary Material Figure S2).
Statistical analysis of electrostatic force components and disease-causing mutations. We fur-
ther investigated the unbound state’s ∆F and its ∆F ’s components as predictors of whether a mutation is 
disease-causing or non-disease-causing using histograms (Fig. 4). We found that all mutations in our study with 
∆ >F 16 pN led to disease and that only 9% of the non-disease causing mutations had ∆ >F 4 pN (Fig. 4A).
We also found that kinesins had a higher tolerance to ΔFbind and ΔFlong than to ΔFlat. We found that 
only 9% of the non-disease-causing mutants had ΔFlat > 1 pN while 36% had ΔFbind > 1 pN and 27% had 
ΔFlong > 1 pN (Fig. 4B,C,D). We also noted that mutations causing ΔFlat between 1 pN and 4 pN did a much 
better job distinguishing disease state because this range in ΔFlat contains 35% of all disease-causing but only 9% 
of non-disease-causing mutants, which is statistically significantly different (p-value = 0.02), but this same range 
in ΔFbind and ΔFlong had percentages of disease-causing and non-disease-causing that were statistically indistin-
guishable (Fig. 4B,C,D).
Analysis of additional features that may be used to discriminate disease-causing and 
non-disease-causing mutations. We performed a statistical analysis of 23 features potentially affecting 
the pathogenicity of kinesin mutations using standard techniques (see Supplementary Material). By comparing 
the p-values of an F-regression analysis, we found that electrostatic force was the best predictor (Table 3). The 
other good predictors were the secondary structure of mutation position, change in binding free energy, and the 
location of mutation site (Table 3). The buried surface area, residue polarity, residue charge, etc., were not identi-
fied as significant features in predicting pathogenicity (Table 3).
Figure 2. Definition of forces components. As an illustrative example, kinesin-3 family member KIF1A (light 
blue) is shown in the bound state on a tubulin dimer with α-tubulin (red) on the left side and β-tubulin (orange) 
on the right side. The “longitudinal” direction is along the microtubule, shown (green arrow) positive pointing 
toward the plus end. The “binding” direction is normal to the surface of the microtubule, shown (green arrow) 
positive toward the microtubule lumen. The “lateral” direction is around the microtubule, shown (green 






Components of the unit vector
Lateral Binding Longitudinal
Bound state 1450 ± 170 −0.16 ± 0.17 0.67 ± 0.08 0.10 ± 0.15
Unbound state 192 ± 56 −0.15 ± 0.17 0.77 ± 0.07 −0.01 ± 0.09
Table 2. Mean electrostatic force magnitude and direction. Note: Values are reported as mean ± standard error 
of the mean; n = 10 wild type kinesin proteins.
www.nature.com/scientificreports/
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We found that 88% of the disease-causing mutations occur in α-helices, coils, and turns (Fig. 5A). Only 31% of 
mutations located on strands caused disease, which is significantly fewer than the 61% and 53% disease-causing 
rates for mutations on coils and turns, respectively (Fig. 5A). Our data had few instances of mutations on 3–10 
helices or salt bridges, therefore these mutations are not taken into further analysis.
Additionally, we noted that the disease-causing nature of a mutation was correlated to the function of the 
structure domain upon which it resides. 76% of mutations at the tubulin binding site were disease-causing 
(Fig. 5B), while mutations at other locations were disease-causing in only 46% of instances (Fig. 5B). Note that 
Figure 3. Magnitude of the electrostatic force difference, ΔFrel, can be used to predict whether a mutation is 
disease-causing. ROC plots are of ΔFrel calculated in the bound state (BS Mag, black line), the component of 
force difference in the binding direction, ΔFbind,rel, in the bound state (BS BC, blue line), ΔFrel in the unbound 
(UBS Mag, red line), and ΔFbind,rel in the unbound state (UBS BC, green line). The areas below these four ROC 
curves are: 0.79, 0.77, 0.84, 0.84, respectively.
Figure 4. Whether a mutation causes a disease or not is correlated to the electrostatic force differences. 
Normalized histograms of disease-causing (black) and non-disease-causing (gray) mutations by electrostatic 
force difference when kinesin is in the unbound state for (A) ∆F , (B) ΔFbind, (C) ΔFlat, and (D) ΔFlong. Total 
mutation counts are labeled on each bar. Note that our dataset included a total of 50 disease-causing mutants 
and 11 non-disease-causing mutants. The error bars indicate the standard deviation.
www.nature.com/scientificreports/
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since this study focused on the kinesin-tubulin interaction, mutations on ATP binding site were not taken into 
further discussion.
Discussion
We demonstrated that the changes of the electrostatic component of the force between kinesin and micro-
tubule caused by amino acid mutations in the kinesin motor domain serve as a good discriminator between 
disease-causing and non-disease-causing mutations. 23 other features typically used by the computational com-
munity were also investigated, but we found them to be not as good predictors of disease state as the change of 
the electrostatic force. These results are remarkable because kinesin-related diseases may originate from nsSNPs 
causing effects within the motor domain not related to kinesin-microtubule binding. These effects may include 
disruption of nucleotide hydrolysis site because motility requires ATP hydrolysis62, proximity of the mutation to 
the location neck-linker-motor domain interaction site because motility requires neck linker docking63, 64, and 
motor domain structural stability because structure and function are closely correlated in structured proteins. 
Additionally, the kinesin family to which the mutated protein belongs could also be an important factor because 
certain families may have more critical cell or developmental biological function than others, and certain fami-
lies may have fewer functional redundancies with other motors within the family than others65. Moreover, that 
our results show electrostatic force is a good discriminator between disease-causing and non-disease causing 
mutations suggests that there is steep electrostatic potential energy well about the kinesin docking location on 
the microtubule. Because the force is proportional to the spatial gradient of potential energy, small changes in the 
electrostatic energy potential result in large change in the force. Therefore, it is likely that electrostatic force is an 
even better discriminator than electrostatic energy potential.
We checked if our results were biased by the location of the mutations sites relative to the kinesin-microtubule 
binding interface by generating a representative kinesin motor domain-tubulin structure (Fig. 6). We note that 
the kinesin motor domains studied in this work have similar structures (Fig. 6A), and thus we use one (kinesin-3) 
to visualize the location of mutations sites (Fig. 6B). We found that there is no preference for disease-causing 
mutations to be at the binding interface while non-disease-causing mutations are away.
Recent studies indicate that positively charged residues on the kinesin motor domain strengthens its inter-
action with the microtubule, while negatively charged residues have an opposite effect22, 23, 25, 66. Consistent with 
these previous studies, we have found that most of the disease-causing mutations we studied involve charged 
residues. Our findings provide additional evidence for the importance of charged residues and electrostatics to 
kinesin motor domain microtubule binding. Furthermore, we found that Y274 and L248, which were previously 
identified as the top two most important uncharged residues for kinesin-microtubule binding22, 66, were also 
associated with disease-causing mutations in kinesin-3 family member KIF1A (L249Q) and in kinesin-1 family 
Numerical Features




Difference in total force at 5 Å distance 0.02 5.33
Absolute difference in binding force at 5 Å distance 0.03 5.19
Absolute difference in longitudinal force at 5 Å distance 0.06 3.68
Absolute difference in lateral force at 5 Å distance 0.07 3.40
Change in charge 0.12 2.51
Change in binding free energy 0.13 2.38
Change in buried surface area 0.23 1.49
Absolute difference in longitudinal force at bound state 0.24 1.42
Difference in total force at bound state 0.25 1.34
Absolute difference in longitudinal force at bound state 0.25 1.34
Absolute difference in binding force at bound state 0.28 1.18
Absolute difference in lateral force at bound state 0.30 1.09
Difference in longitudinal force at bound state 0.35 0.90
Difference in binding force at bound state 0.39 0.74
Change in folding free energy 0.40 0.71
Difference in lateral force at bound state 0.47 0.53
Difference in binding force at 5 Å Distance 0.57 0.33
Difference in lateral force at 5 Å Distance 0.60 0.28
Difference in longitudinal force at 5 Å Distance 0.69 0.16
Categorical Features Logistic Regression Coefficient
Change in polarity 0.46
Residue on binding site −0.01
Residue exposure −0.08
Secondary structure of mutation residue −0.23
Table 3. Statistical analysis of 23 possible features.
www.nature.com/scientificreports/
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member KIF5A (Y276C). The correspondence between important previously identified charged and uncharged 
residues22, 66 and disease-association allows us to speculate that mutations at other positions identified as impor-
tant in previous studies22, 66 including R346, K44, and K261, which do not appear in our database, are likely to be 
disease-causing.
Our key result is that if a mutation causes a ∆ >F 4 pN in the unbound state, then it is very likely to cause 
disease. Such a threshold roughly corresponds to 1 kcal/mol binding energy, an energy threshold that is widely 
used to discriminate disease-causing from non-disease-causing mutations67. Below we investigate a few particular 
mutants more closely, as illustrative examples, to understand our result a bit better.
First, we noted that kinesin-3 family member KIF1A E253K is charge reversal, from a negatively charged 
glutamic acid residue to a positively charged lysine residue, and it resulted in the largest ∆F  (Supplementary 
Material Table S1) in both the bound and unbound states. We looked carefully at the magnitude and direction of 
the force on each amino acid in this kinesin-3 (Fig. 7). We found that the mutated amino acid lies close to the 
tubulin interface: the distance between the CA atom of E253 and the closest CA atom on tubulin is 9.6 Å. Because 
the mutation flips the charge of the residue and it is so close to the highly-charged tubulin interface, the large 
change in force we calculated was likely do the negative-to-positive charge reversal. The negatively charged E253 
in wild type kinesin-3 opposes binding (Fig. 7 red arrow), and the positively charged K253 in the mutant 
kinesin-3 favors binding (Fig. 7 blue arrow), to the net negatively charged tubulin dimer. It is therefore not sur-
prising that the enhanced binding due to this mutation causes spastic paraparesis and sensory and autonomic 
neuropathy type-239 given that kinesin-3 drives long-distance transport in neuronal cells9.
Second, we noted that kinesin-8 family member KIF18A T273A mutant is the only non-disease causing 
mutant with a ∆ >F 4 pN; it had ∆ = .F 4 92 pN. We looked carefully at the location of this residue in the 
structure and found it to reside on an unstructured region (or at least one that is not in the PDB ID 3LRE struc-
ture)68 on the microtubule binding surface22, thus leading to a relatively large calculated ∆F . However, the T273 
is not highly conserved and the T273A does not change the motility of the kinesin in in vitro motility assays22. 
This could explain how this mutation is non-disease-causing despite relatively large ∆F .
Third, we noted that the kinesin-1 family member KIF5A S203C mutant has a low ∆ = .F 1 27 pN in the 
unbound state (Supplementary Material Table S1), well below the discrimination threshold of 4 pN, but is 
disease-causing. We looked carefully at the location of this mutation, and found it is located in close proximity 
Figure 5. Location of the mutation is correlated to its likelihood of causing disease. (A) Histograms indicating 
which secondary structure the mutated residue is on for disease-causing and non-disease-causing mutants. (B) 
Histograms indicating whether the mutated residue is on the microtubule binding interface or not for disease-
causing and non-disease-causing mutants.
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(5.5 Å) to the Mg2+ ion in the nucleotide binding site69. Specifically, S203 resides within a highly conserved 
sequence (NXXSSR, residues 199–204 of KIF5A) in switch I30, and it is thought to be important in recognizing 
the hydrolysis state of bound the nucleotide70. This could explain how this mutation causes a disease despite low 
∆F , highlighting our discrimination method’s limitation in finding all the true positive cases, particularly when 
mutations are unrelated to the kinesin-tubulin interaction.
While we did find that ∆ >F 4 pN in the unbound state is an excellent discriminator, we also found that 
the three components of the relative force difference, ΔFlong,rel, ΔFlat,rel, and ΔFbind,rel, are also successful predic-
tors, in their own right. These results suggest that the individual components of the binding force, particularly the 
lateral and longitudinal components, may be of critical importance for kinesin motility. It should be additionally 
noted that the magnitude of the electrostatic force is significantly (least 5-fold) larger in the binding direction 
Figure 6. Mutations distribution map. (A) The structural alignment for all the kinesin-tubulin dimer structures 
studied, each color representing a different kinesin structure. (B) Mutations sites mapped on a representative 
kinesin structure (kinesin-3 family member, KIF1A). Red residues indicate disease-causing mutation sites 
and yellow residues indicate non-disease-causing mutation sites. α-tubulin (red) is on the left and β-tubulin 
(orange) is on the right in both panels.
Figure 7. Forces on each residue of kinesin-3 show the large change in relative force due to the mutation. 
Kinesin-3 family member KIF1A (light blue) with the E253K mutation is shown bound to a tubulin dimer 
with α-tubulin (red) on the left side and β-tubulin (orange) on the right side. Most electrostatic forces (yellow 
arrows) on each residue of the kinesin-3 remain unchanged, but the force on residue 253 changes with the 
mutation, with both the force on wild type (red arrow) and the force on the mutant (blue arrow) shown.
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than the other two directions (Table 1). Thus, it is likely to be less sensitive to the changes in magnitude than the 
other directions. If a mutation changes the force in the binding direction a given amount, kinesin may still bind 
to tubulin properly, however if the force in the lateral or longitudinal direction were changed by that same 
amount, it may be significantly more sensitive to the difference. It should be noted that the absolute value of the 
electrostatic force change was found to be the best discriminator. Thus, mutations strengthening the binding are 
equally likely to be disease-causing as mutations weakening it. This is consistent with previous studies on other 
systems, indicating that these systems are optimized and any deviation away from the wild type properties could 
be disease-causing4, 67.
Finally, it should be noted that this study considers the electrostatic component of the force acting between 
the kinesin and tubulin, not the total force. A kinesin motor domain that is not subjected to other external force, 
e.g. a cargo load, is at equilibrium on the microtubule. Therefore, at equilibrium, non-electrostatic forces must be 
acting at the tubulin-kinesin interface to balance out the large magnitude electrostatic forces we have calculated.
References
 1. Srinivasan, S., Clements, J. A. & Batra, J. Single nucleotide polymorphisms in clinics: Fantasy or reality for cancer? Critical reviews 
in clinical laboratory sciences 53, 29–39 (2016).
 2. Brookes, A. J. & Robinson, P. N. Human genotype-phenotype databases: aims, challenges and opportunities. Nature Reviews 
Genetics 16, 702–715 (2015).
 3. Leu, C., Coppola, A. & Sisodiya, S. M. Progress from genome-wide association studies and copy number variant studies in epilepsy. 
Current opinion in neurology 29, 158–167 (2016).
 4. Kucukkal, T. G., Petukh, M., Li, L. & Alexov, E. Structural and physico-chemical effects of disease and non-disease nsSNPs on 
proteins. Current opinion in structural biology 32, 18–24 (2015).
 5. Alexov, E. & Sternberg, M. Understanding molecular effects of naturally occurring genetic differences. Journal of molecular biology 
21, 3911–3913 (2013).
 6. Kucukkal, T. G., Yang, Y., Chapman, S. C., Cao, W. & Alexov, E. Computational and experimental approaches to reveal the effects of 
single nucleotide polymorphisms with respect to disease diagnostics. International journal of molecular sciences 15, 9670–9717 
(2014).
 7. Zhang, Z., Miteva, M. A., Wang, L. & Alexov, E. Analyzing effects of naturally occurring missense mutations. Computational and 
mathematical methods in medicine 2012 (2012).
 8. Endow, S. A., Kull, F. J. & Liu, H. Kinesins at a glance. J Cell Sci 123, 3420–3424 (2010).
 9. Hirokawa, N. & Tanaka, Y. Kinesin superfamily proteins (KIFs): various functions and their relevance for important phenomena in 
life and diseases. Experimental cell research 334, 16–25 (2015).
 10. Vale, R. D., Reese, T. S. & Sheetz, M. P. Identification of a novel force-generating protein, kinesin, involved in microtubule-based 
motility. Cell 42, 39–50 (1985).
 11. Howard, J., Hudspeth, A. & Vale, R. Movement of microtubules by single. Nature 342, 9 (1989).
 12. Hirokawa, N., Noda, Y., Tanaka, Y. & Niwa, S. Kinesin superfamily motor proteins and intracellular transport. Nature reviews 
Molecular cell biology 10, 682–696 (2009).
 13. Howard, J. Mechanics of motor proteins and the cytoskeleton. (Sinauer Associates, 2001).
 14. Lawrence, C. J. et al. A standardized kinesin nomenclature. The Journal of cell biology 167, 19–22 (2004).
 15. Desai, A., Verma, S., Mitchison, T. J. & Walczak, C. E. Kin I kinesins are microtubule-destabilizing enzymes. Cell 96, 69–78 (1999).
 16. Helenius, J., Brouhard, G., Kalaidzidis, Y., Diez, S. & Howard, J. The depolymerizing kinesin MCAK uses lattice diffusion to rapidly 
target microtubule ends. Nature 441, 115–119 (2006).
 17. Walker, R. A., Salmon, E. D. & Endow, S. A. The Drosophila claret segregation protein is a minus-end directed motor molecule. 
Nature 347, 780 (1990).
 18. McDonald, H. B., Stewart, R. J. & Goldstein, L. S. The kinesin-like ncd protein of Drosophila is a minus end-directed microtubule 
motor. Cell 63, 1159–1165 (1990).
 19. Gittes, F., Meyhöfer, E., Baek, S. & Howard, J. Directional loading of the kinesin motor molecule as it buckles a microtubule. 
Biophysical Journal 70, 418–429 (1996).
 20. Visscher, K., Schnitzer, M. J. & Block, S. M. Single kinesin molecules studied with a molecular force clamp. Nature 400, 184–189 
(1999).
 21. Hancock, W. O. & Howard, J. Kinesin’s processivity results from mechanical and chemical coordination between the ATP hydrolysis 
cycles of the two motor domains. Proceedings of the National Academy of Sciences 96, 13147–13152 (1999).
 22. Woehlke, G. et al. Microtubule interaction site of the kinesin motor. Cell 90, 207–216 (1997).
 23. Grant, B. J. et al. Electrostatically biased binding of kinesin to microtubules. PLoS Biol 9, e1001207 (2011).
 24. Ray, S., Meyhöfer, E., Milligan, R. A. & Howard, J. Kinesin follows the microtubule’s protofilament axis. The Journal of cell biology 
121, 1083–1093 (1993).
 25. Li, L., Alper, J. & Alexov, E. Multiscale method for modeling binding phenomena involving large objects: application to kinesin 
motor domains motion along microtubules. Scientific reports 6 (2016).
 26. Bormuth, V., Varga, V., Howard, J. & Schäffer, E. Protein friction limits diffusive and directed movements of kinesin motors on 
microtubules. Science 325, 870–873 (2009).
 27. Jannasch, A., Bormuth, V., Storch, M., Howard, J. & Schäffer, E. Kinesin-8 is a low-force motor protein with a weakly bound slip 
state. Biophysical Journal 104, 2456–2464 (2013).
 28. Chandrasekaran, G., Tátrai, P. & Gergely, F. Hitting the brakes: targeting microtubule motors in cancer. British journal of cancer 113, 
693–698 (2015).
 29. Goizet, C. et al. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Human mutation 
30, E376–E385 (2009).
 30. Musumeci, O. et al. A novel mutation in KIF5A gene causing hereditary spastic paraplegia with axonal neuropathy. Neurological 
Sciences 32, 665–668 (2011).
 31. Schüle, R. et al. SPG10 is a rare cause of spastic paraplegia in European families. Journal of Neurology, Neurosurgery & Psychiatry 79, 
584–587 (2008).
 32. Tessa, A. et al. A novel KIF5A/SPG10 mutation in spastic paraplegia associated with axonal neuropathy. Journal of neurology 255, 
1090–1092 (2008).
 33. Crimella, C. et al. Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal 
Charcot–Marie–Tooth type 2. Clinical genetics 82, 157–164 (2012).
 34. Kawaguchi, K. Role of kinesin-1 in the pathogenesis of SPG10, a rare form of hereditary spastic paraplegia. The Neuroscientist 19, 
336–344 (2013).
 35. Fichera, M. et al. Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia. Neurology 63, 
1108–1110 (2004).
www.nature.com/scientificreports/
1 1SCientifiC REPoRTs | 7: 8237  | DOI:10.1038/s41598-017-08419-7
 36. Poirier, K. et al. Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and 
microcephaly. Nature genetics 45, 639–647 (2013).
 37. Ostergaard, P. et al. Mutations in KIF11 cause autosomal-dominant microcephaly variably associated with congenital lymphedema 
and chorioretinopathy. The American Journal of Human Genetics 90, 356–362 (2012).
 38. Min, B.-J. et al. Whole-exome sequencing identifies mutations of KIF22 in spondyloepimetaphyseal dysplasia with joint laxity, 
leptodactylic type. The American Journal of Human Genetics 89, 760–766 (2011).
 39. Lee, J. R. et al. De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal 
neuropathy, and cerebellar atrophy. Human mutation 36, 69–78 (2015).
 40. Liu, X., Wu, C., Li, C. & Boerwinkle, E. dbNSFP v3. 0: A One‐Stop Database of Functional Predictions and Annotations for Human 
Nonsynonymous and Splice‐Site SNVs. Human mutation 37, 235–241 (2016).
 41. Stenson, P. D. et al. The human gene mutation database: 2008 update. Genome medicine 1, 13 (2009).
 42. Landrum, M. J. et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic acids research 44, D862–D868 
(2016).
 43. Siva, N. 1000 Genomes project. Nature Biotechnology 26, 256–261 (2008).
 44. Berman, H., Henrick, K., Nakamura, H. & Markley, J. L. The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform 
archive of PDB data. Nucleic acids research 35, D301–D303 (2007).
 45. Project, G. Variation in genome-wide mutation rates within and between human families. Nature genetics 43, 712–714 (2011).
 46. Berman, H., Henrick, K. & Nakamura, H. Announcing the worldwide protein data bank. Nature Structural & Molecular Biology 10, 
980–980 (2003).
 47. Guex, N. & Peitsch, M. C. SWISS‐MODEL and the Swiss‐Pdb Viewer: an environment for comparative protein modeling. 
electrophoresis 18, 2714–2723 (1997).
 48. Xiang, Z. Advances in homology protein structure modeling. Current Protein and Peptide Science 7, 217–227 (2006).
 49. Nelson, M. T. et al. NAMD: a parallel, object-oriented molecular dynamics program. International Journal of High Performance 
Computing Applications 10, 251–268 (1996).
 50. Vanommeslaeghe, K. et al. CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐
atom additive biological force fields. Journal of Computational Chemistry 31, 671–690 (2010).
 51. Mizuno, N. et al. Dynein and kinesin share an overlapping microtubule‐binding site. The EMBO journal 23, 2459–2467 (2004).
 52. Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. Journal of Computational 
Chemistry 25, 1605–1612 (2004).
 53. Vemu, A. et al. Structure and dynamics of single-isoform recombinant Neuronal Human Tubulin. Journal of Biological Chemistry 
291, 12907–12915 (2016).
 54. Goulet, A. et al. The structural basis of force generation by the mitotic motor kinesin-5. Journal of Biological Chemistry 287, 
44654–44666 (2012).
 55. Huang, J. & MacKerell, A. D. CHARMM36 all‐atom additive protein force field: Validation based on comparison to NMR data. 
Journal of Computational Chemistry 34, 2135–2145 (2013).
 56. Brooks, B. R. et al. CHARMM: The Biomolecular Simulation Program. Journal of Computational Chemistry 30, 1545–1614, 
doi:10.1002/jcc.21287 (2009).
 57. Dolinsky, T. J., Nielsen, J. E., McCammon, J. A. & Baker, N. A. PDB2PQR: an automated pipeline for the setup of Poisson–Boltzmann 
electrostatics calculations. Nucleic acids research 32, W665–W667 (2004).
 58. Li, L., Chakravorty, A. & Alexov, E. DelPhiForce, a tool for electrostatic force calculations: Applications to macromolecular binding. 
Journal of Computational Chemistry (2017).
 59. Li, L. et al. DelPhi: a comprehensive suite for DelPhi software and associated resources. BMC biophysics 5, 9 (2012).
 60. Li, L., Li, C., Zhang, Z. & Alexov, E. On the dielectric “constant” of proteins: smooth dielectric function for macromolecular 
modeling and its implementation in Delphi. Journal of chemical theory and computation 9, 2126–2136 (2013).
 61. Li, L., Alper, J. & Alexov, E. Cytoplasmic dynein binding, run length, and velocity are guided by long-range electrostatic interactions. 
Scientific reports 6 (2016).
 62. Coy, D. L., Wagenbach, M. & Howard, J. Kinesin takes one 8-nm step for each ATP that it hydrolyzes. Journal of Biological Chemistry 
274, 3667–3671 (1999).
 63. Cao, L. et al. The structure of apo-kinesin bound to tubulin links the nucleotide cycle to movement. Nature communications 5 
(2014).
 64. Muretta, J. M. et al. The structural kinetics of switch-1 and the neck linker explain the functions of kinesin-1 and Eg5. Proceedings of 
the National Academy of Sciences 112, E6606–E6613 (2015).
 65. Goldstein, L. S. The kinesin superfamily: tails of functional redundancy. Trends in cell biology 1, 93–98 (1991).
 66. Li, M. & Zheng, W. Probing the Structural and Energetic Basis of Kinesin–Microtubule Binding Using Computational Alanine-
Scanning Mutagenesis. Biochemistry 50, 8645–8655 (2011).
 67. Petukh, M., Kucukkal, T. G. & Alexov, E. On Human Disease‐Causing Amino Acid Variants: Statistical Study of Sequence and 
Structural Patterns. Human mutation 36, 524–534 (2015).
 68. Peters, C. et al. Insight into the molecular mechanism of the multitasking kinesin‐8 motor. The EMBO journal 29, 3437–3447 (2010).
 69. Atherton, J. et al. Conserved mechanisms of microtubule-stimulated ADP release, ATP binding, and force generation in transport 
kinesins. Elife 3, e03680 (2014).
 70. Kikkawa, M. The role of microtubules in processive kinesin movement. Trends in cell biology 18, 128–135 (2008).
 71. Morikawa, M. et al. X‐ray and Cryo‐EM structures reveal mutual conformational changes of Kinesin and GTP‐state microtubules 
upon binding. The EMBO journal 34, 1270–1286 (2015).
 72. Yamagishi, M. et al. Structural Basis of Backwards Motion in Kinesin-1-Kinesin-14 Chimera: Implication for Kinesin-14 Motility. 
Structure 24, 1322–1334 (2016).
 73. Kikkawa, M. & Hirokawa, N. High‐resolution cryo‐EM maps show the nucleotide binding pocket of KIF1A in open and closed 
conformations. The EMBO journal 25, 4187–4194 (2006).
 74. Chang, Q., Nitta, R., Inoue, S. & Hirokawa, N. Structural basis for the ATP-induced isomerization of kinesin. Journal of molecular 
biology 425, 1869–1880 (2013).
 75. Turner, J. et al. Crystal structure of the mitotic spindle kinesin Eg5 reveals a novel conformation of the neck-linker. Journal of 
Biological Chemistry 276, 25496–25502 (2001).
 76. Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. Journal of molecular graphics 14, 33–38 (1996).
Acknowledgements
The work of L.L., Z.J., Y.P., I.G. and E.A. was supported by a grant from the Institute of General Medical Sciences, 
National Institutes of Health, award number R01GM093937.
www.nature.com/scientificreports/
1 2SCientifiC REPoRTs | 7: 8237  | DOI:10.1038/s41598-017-08419-7
Author Contributions
L.L. and Z.J. designed the research, analyzed the data and drafted the manuscript. Y.P. and S.G. analyzed the data, 
I.G. and S.T. prepared the structures, J.A. and E.A. designed the research, drafted the manuscript and supervised 
the whole project.
Additional Information
Supplementary information accompanies this paper at doi:10.1038/s41598-017-08419-7
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
